Merk’s dirty little secret has been exposed.
A pair of lawsuits, one filed by former employees of Merck and the other by doctors, alleged the company knew its mumps vaccine was less effective than the supposed 95 percent efficiency level.
According to court documents the former virologists employed by Merck filed a whistleblower lawsuit four years ago claiming that senior management was aware, complicit and in charge of the testing that concealed the actual effectiveness.
Former Employees Suggest Merck Concealed Vaccination Data
Did Merck use false pretenses to monopolize the market for mumps vaccine?
According to the former employee’s lawsuit, they claim to have witnessed firsthand improper testing and data falsification by the company in order to conceal what they knew about the vaccine’s weakened efficiency.
The lawsuit suggests that senior management and their superiors pressured the former employees to take park in the fraud and cover up when they objected and tried to stop it.
According to court documents, physicians filed a lawsuit against the company claiming the vaccine was mislabeled and was not the product for which the government or other purchasers paid, which meant that Merck was in violation of the False Claims Act.
Both lawsuits note that Merck held an exclusive license to sell a mumps vaccine and its actions discouraged competition.
Children Are the Ultimate Victims
The lawsuit filed by the virologist’s states, “The ultimate victims here are the millions of children who, every year, are being injected with a mumps vaccine that is not providing them with an adequate level of protection.”
And while federal health officials have said the disease was supposed to be eradicated by now, “The failure of Merck’s vaccine has allowed this disease to linger with significant outbreaks continuing to occur.”
According to the CDC, last year 438 people in 39 states in the U.S. were reported to have mumps. From Jan.1 through Aug. 15 of this year 965 people in the U.S. were reported to have mumps and outbreaks in at least four U.S. states. Universities contributed to these cases.
Yet again we see how big pharma stops at nothing to promote sales.